Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO ASSETS RATIO
N/A
Apnimed, Inc.
Market Cap
$802.84M
Debt to Assets Ratio
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Apnimed, Inc. (APMD) | $802.84M | N/A |
| InMode Ltd. (INMD)vs › | $803.27M | 0.01% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $797.15M | 0.02% |
| Ardelyx, Inc. (ARDX)vs › | $815.52M | 0.44% |
| AdaptHealth Corp. (AHCO)vs › | $782.99M | 0.48% |
| Jade Biosciences, Inc. (JBIO)vs › | $828.30M | 0.00% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | 0.24% |
| Alumis Inc. (ALMS)vs › | $834.01M | 0.06% |
| Geron Corporation (GERN)vs › | $777.20M | 0.24% |
| Beta Bionics, Inc. (BBNX)vs › | $838.09M | 0.02% |
Debt/Assets
N/A
Debt/Equity
N/A
Current Ratio
N/A
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
